In a Phase 1a escalating clinical trial, autologous mesenchymal stem cell infusion for renovascular disease increases blood flow and the glomerular filtration rate while reducing inflammatory biomarkers and blood pressure.

Atherosclerotic renovascular disease (ARVD) reduces tissue perfusion and eventually leads to loss of kidney function with limited therapeutic options. Here we describe results of Phase 1a escalating dose clinical trial of autologous mesenchymal stem cell infusion for ARVD. Thirty-nine patients with...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Kidney Int
Main Authors: Abumoawad, Abdelrhman, Saad, Ahmed, Ferguson, Christopher M., Eirin, Alfonso, Herrmann, Sandra M., Hickson, LaTonya J., Goksu, Busra B., Bendel, Emily, Misra, Sanjay, Glockner, James, Dietz, Allan B., Lerman, Lilach O., Textor, Stephen C.
Format: Artigo
Sprog:Inglês
Udgivet: 2019
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7284953/
https://ncbi.nlm.nih.gov/pubmed/32093917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.kint.2019.11.022
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker